Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT04168697 Not yet recruiting - Bipolar Disorder I Clinical Trials

Effect of Behavioral Intervention on Cannabinoid Receptors in BAD

WHM_BAD
Start date: February 1, 2020
Phase: N/A
Study type: Interventional

The objective of this study is to determine whether the practice of a non-drug related intervention technique (behavioral modification technique consisting of a combination of breathing exercises, cold exposure and meditation) has an effect on long-term cannabinoid receptor function in a control group as well as in a group of patients suffering from bipolar affective disorder (BAD). Specifically, the objective of this study is to test whether the applied behavioral modification technique is able to alter cannabinoid receptor density in brain areas that modulate mood and motivational drive (such as vmPFC, PAG, VTA, amygdala and OFC). The investigators believe that these studies will form the impetus for a better understanding and deployment of non-drug related treatment methods in patients with various depressive symptoms. In particular, it appears that the proposed behavioral modification technique might be a powerful, currently under-appreciated, method to positively modulate the brain's own cannabinoid system.

NCT ID: NCT04167878 Not yet recruiting - Clinical trials for Symptomatic Cervical Disc Disease

Exploratory Study of 3D Printed Biodegradable Cervical Interbody Fusion Cage

Start date: December 1, 2019
Phase: N/A
Study type: Interventional

A small sample, single center, non-randomized, noninferiority clinical trial to evaluate the safety and effectiveness of 3D printed biodegradable cervical interbody fusion cage in anterior cervical discectomy and fusion (ACDF) for treating patients with a symptomatic degenerative cervical disc disease at one level from C2/C4 to C7/T1.

NCT ID: NCT04163770 Not yet recruiting - Clinical trials for Disorder of Cardiac Pacemaker System

Evaluation Of Pacemakers in Children

Start date: January 15, 2020
Phase: N/A
Study type: Interventional

Pacemakers were introduced into clinical practice several decades ago and currently are used in a growing number of patients. Since insertion of the first cardiac Pacemaker in 1958, vast changes have occurred in both the technology of the devices and their indications. Devices have evolved from single-lead and fixed-rate systems to multi chamber rate-responsive systems with increasingly sophisticated software . Pediatric Pacemaker implants comprise less than 1 % of all implants. The indications for pacing in newborns and infants are divided predominantly into three groups: congenital abnormalities of the conduction system, acquired heart blocks after cardiac surgery for correction of congenital defects, and sinus node diseases

NCT ID: NCT04163133 Not yet recruiting - Clinical trials for Whether Delay of Trigger Will Obtain More Good-quality Embryos

Trigger Timing in Ovarian Stimulations

Start date: December 1, 2019
Phase: N/A
Study type: Interventional

The use of antagonist ovulation stimulation program is increasing year by year, because of its convenience, flexibility, and prevention effect of ovarian hyperstimulation syndrome. However, many researchers and clinicians believe that the clinical outcomes of antagonist regimens are worse than those of classical long-term regimens. Studies showed that the reasons for that maybe antagonist protocol results in poor effect on oocytes maturation or endometrial receptivity. At present, the trigger time of antagonist regimen is more than three follicles with diameters of ≥17 mm, which makes the duration of gonadotrophin application in antagonist regimen is shorter than that of long regimen. Whether the trigger time of antagonist regimen is too early to cause adverse effects on oocytes, embryos and eventual clinical outcomes is unknown. This study hopes to compare regular trigger timing and two days delay of trigger in ovarian stimulations by antagonist protocol,in order to study whether delay two days of trigger will get better clinical outcomes than regular trigger timing in ovarian stimulations by antagonist protocol in in vitro fertilization (IVF)/Intracytoplasmic sperm injection (ICSI). The results of this study will help infertile couples and clinicians to know and choose the optimal treatment in antagonist protocol.

NCT ID: NCT04161742 Not yet recruiting - Clinical trials for Focus of Study: Patients With Suspicion of Melanoma

Clinical Utility of Electrical Impedance Spectroscopy

Start date: December 2019
Phase: N/A
Study type: Interventional

The purpose of this clinical study is to evaluate the clinical utility of the Nevisense in normal clinical practice, i.e. the potential effect of implementing Nevisense in clinical decision making (Human vs Human & Machine) based on Nevisense measurement at time of biopsy decision.

NCT ID: NCT04161508 Not yet recruiting - Clinical trials for Other Fusion of Spine, Cervical Region

Enhanced Recovery After Surgery for Anterior Cervcial Spine Surgeries in Elderly Patients

Start date: December 20, 2019
Phase: N/A
Study type: Interventional

Elderly patients are subjected to airway and other complications after cervical spine surgeries. The study aim to investigate the efficacy of sugammadex (vs. neostigmine) in the recovery after anterior cervical spine surgery.

NCT ID: NCT04160338 Not yet recruiting - Clinical trials for Accelerated Corneal Collagen Cross Linking

Assessment of Corneal Endothelium After Collagen Cross Linking

CXL
Start date: December 2019
Phase:
Study type: Observational

The aim of this study is to assess the effect of accelerated corneal collagen cross linking on corneal endothelium using the specular microscopy

NCT ID: NCT04159441 Not yet recruiting - Clinical trials for Chemical and Drug Induced Liver Injury

Hepatotoxicity of Antituberculosis Therapy (HAT) Study

HAT
Start date: December 5, 2019
Phase:
Study type: Observational [Patient Registry]

Drug-induced liver injury (DILI) is a common side effect in antituberculosis therapy, which interuputs the treatment of TB and leads to a higher proportion of Multidrug-Resistence TB(MDR-TB).The study primalily aims to observe the proportion of DILI in antituberculosis therapy. Furthermore, the secondary objective is to study the proportion of liver injury of based liver disase,liver failure and adjustment of chemotherapy in the obersevational study.

NCT ID: NCT04158024 Not yet recruiting - Clinical trials for Congenital Heart Disease in Children

Erector Spinae Plane Block in Congenital Heart Disease Patients

Start date: January 2024
Phase: N/A
Study type: Interventional

Pediatric cardiac patients undergoing surgical anesthesia are at an increased risk of poor neurologic outcome (20-50%). Unattenuated anesthetic exposure and pain contributes to physiologic perturbations that may increase neurologic morbidity. Because of the often-large exposure to anesthetic agents in these cardiac children, at such a young age and the potential modifying anesthetic practice that could lead to improved neurodevelopmental outcomes and surgical recovery is paramount. Regional anesthesia such as thoracic epidurals provide effective analgesia and reduced intraoperative anesthetic needed but carry devastating sequelae neurological risks of epidural hematomas after anticoagulation during cardiopulmonary bypass (CPB). Recently, a newly described erector spinae plane block (ESPB) is superficial to neuraxial or vascular structures, providing opportunity to be placed with less risk for surgery requiring CPB. This block has been described as effective regional anesthesia for adult cardiac surgery.

NCT ID: NCT04157868 Not yet recruiting - Clinical trials for ST-Segment Elevated Myocardial Infarction

Early rhBNP on Myocardial Work in Patients With STEMI

Start date: November 30, 2019
Phase: Phase 4
Study type: Interventional

The study intends to evaluate the efficacy of early rhBNP on myocardial work in patients with anterior ST-segment elevation myocardial infarction after percutaneous coronary intervention